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The virulence of Salmonella is linked to its invasive
capacity and suppression of adaptive immunity.
This does not explain, however, the rapid dissemina-
tion of the pathogen after it breaches the gut. In our
study, S. Typhimurium suppressed degranulation of
local mast cells (MCs), resulting in limited neutrophil
recruitment and restricting outflow of vascular con-
tents into infection sites, thus facilitating bacterial
spread. MC suppression was mediated by secreted
effector protein (SptP), which shares structural
homology with Yersinia YopH. SptP functioned by
dephosphorylating the vesicle fusion protein N-eth-
ylmalemide-sensitive factor and by blocking phos-
phorylation of Syk. Without SptP, orally challenged
S. Typhimurium failed to suppress MC degranulation
and exhibited limited colonization of the mesenteric
lymph nodes. Administration of SptP to sites of
E. coli infection markedly enhanced its virulence.
Thus, SptP-mediated inactivation of local MCs is a
powerful mechanism utilized by S. Typhimurium to
impede early innate immunity.
INTRODUCTION
The bacterial pathogen Salmonella enterica serovar Typhimu-
rium (S. Typhimurium) is a leading cause of food-related deaths,
particularly among immunocompromised individuals (Mead
et al., 1999; Santos et al., 2009). S. Typhimurium virulence has
been associated with the ability to evade and suppress the
host immune system. Some of the earliest studies investigating
the pathogenesis of S. Typhimurium highlighted its remarkable1108 Immunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Incapacity to invade and persist intracellularly within gut epithelial
cells and neighboring macrophages (Haraga et al., 2008), where
it can replicate while avoiding immune cells and antimicrobial
agents. Invasion and intracellular persistence are mediated
by a variety of effector proteins encoded in S. Typhimurium
pathogenicity islands 1 and 2 (SPI-1 and SPI-2, respectively);
the majority of these are exported out of the bacterial cell by
the well-characterized type III secretion system (T3SS) (Gala´n,
2001). One such effector is secreted effector protein (SptP,
also known as Salmonella protein tyrosine phosphatase),
which reverses cytoskeletal changes associated with S. Typhi-
murium entry into host cells to a preinvasion state (Fu and Gala´n,
1999).
More recently, S. Typhimurium has been found to directly
suppress host adaptive immune responses by impeding the
actions of specific immune cells; for example, S. Typhimurium
induces antigen-presenting cells to adopt distinct migratory
paths (Cheminay et al., 2005; Hornef et al., 2002; McLaughlin
et al., 2009) and restricts T cell proliferation and activation to
limited regions of the body after infection (van der Velden
et al., 2005; van der Velden et al., 2008). Other studies have
pointed to a more global mechanism for the suppression of
adaptive immune responses; it involves targeting the draining
lymph node, which is the epicenter of the adaptive immune
response (St John and Abraham, 2009). S. Typhimurium has
been shown to target and disrupt the architecture of lymph
nodes by altering homeostatic chemokine gradients and thus
result in aberrant immune cell trafficking and an ineffective mem-
ory response to the pathogen.
Although S. Typhimurium is able to profoundly modulate
specific immune responses to primary and therefore subsequent
infections, there is also evidence that this pathogen avoids or
actively suppresses the more immediate and nonspecific host
innate immune response. For example, S. Typhimurium avoids
recognition by pattern-recognition receptors (PRRs), such as
Toll-like receptor 4 (TLR4) (Gunn et al., 2000; Guo et al., 1997),c.
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ever, this does not explain the ability of S. Typhimurium to rapidly
proliferate, given that other bacterial components, such as
flagella, are readily recognized by the host PRR repertoire. The
lack of an adequate innate immune response to control S.
Typhimurium growth and spread suggests a more profound
bacteria-mediated mechanism to delay or completely suppress
nonspecific host responses.
An important component of the innate immune response to
bacterial pathogens is the mast cell (MC), a morphologically
distinct type of immune cell that has specialized secretory func-
tions and is preferentially located in close proximity to the epithe-
lium of the gastrointestinal tract and other mucosal surfaces.
Given their strategic location at potential sites of pathogen entry,
MCs are among the first immune cells to perceive and react to
microbial penetration of the epithelial barrier (Abraham and St
John, 2010; Marshall, 2004). There is now a broad consensus
that MCs are pivotal in initiating early innate immune responses
to invading pathogens. Studies investigating Gram-positive and
Gram-negative bacteria, as well as viruses and fungi (St John
and Abraham, 2013; Urb and Sheppard, 2012), have revealed
that MCs promote the early clearance of pathogens. MCs
possess a large repertoire of receptors that recognize and
respond to various microbial components. The MC response
to microbial challenge is typically biphasic. First, rapid de-
granulation facilitates the release of preformed inflammatory
mediators, including tumor necrosis factor (TNF), proteases,
and histamine, that initiate the early recruitment of immune cells
to sites of infection (St John and Abraham, 2013). This initial
response is followed by de novo synthesis and secretion of
various immune mediators several hours later. This biphasic
response permits MCs to not only initiate but also sustain critical
immune responses for prolonged periods of time. Because MCs
are found in close proximity to the vasculature, many MC-
derived mediators readily traffic into the bloodstream, initiate
blood vessel dilation, and promote the extravasation of various
immune cells (Dawicki and Marshall, 2007; Suto et al., 2006).
MC TNF has been implicated in the early recruitment of neutro-
phils to sites of E. coli infection and other enteric bacterial path-
ogens (Abraham and St John, 2010; Malaviya et al., 1996; Urb
and Sheppard, 2012). Unlike wild-type (WT) controls, infected
mice readily succumb to infections in the absence ofMC-derived
TNF-mediated neutrophil influx (Echtenacher et al., 1996; Mala-
viya et al., 1996). In addition, MCs have also been implicated in
the early recruitment of natural killer (NK) and NK T cells to sites
of dengue virus infection and the resulting prompt viral clearance
from WT mice (King et al., 2000; St John et al., 2011), although
the specific MC mediator responsible for this clearance has
yet to be identified. Cumulatively, there is a large body of evi-
dence pointing to a broad role for MCs in promoting early path-
ogen clearance via immune cell recruitment to sites of infection.
However, to date,S. Typhimurium has proven to be an exception
to this paradigm. Although some studies have indicated that
MCs appear to contribute to S. Typhimurium clearance, the
adoptive transfer of cultured MCs into MC-deficient mice does
not significantly alter S. Typhimurium infection (Chatterjea
et al., 2005). Furthermore, the presence of MCs during severe
S. Typhimurium infection even appears harmful (Piliponsky
et al., 2010).ImmGiven the inconclusive role of MCs during S. Typhimurium
infection, we sought to more closely examine interactions
between MCs and S. Typhimurium in vitro and in vivo in the
present study. We discovered that S. Typhimurium possessed
a remarkable capacity to inhibit the ability of MCs to mount a
degranulation response to powerful stimuli, such as ionomycin
and IgE-mediated antigen recognition, and that this inhibition
was attributable to SptP, a protein tyrosine phosphatase
secreted by S. Typhimurium T3SS. Interestingly, SptP is struc-
turally analogous to several tyrosine phosphatases present in
MCs and mediators found in other pathogens, such as YopH
of Yersinia pestis. We determined that SptP appeared to de-
phosphorylate at least two proteins that are critical for MC
degranulation. Our studies have revealed the distinct ability of
S. Typhimurium to inactivate a key modulator of host innate im-
munity and thereby facilitate stealthy infection.
RESULTS
Failure of Local MCs to Degranulate and Rapidly Recruit
Neutrophils after S. Typhimurium Infection
MCs possess an apparent inability to evoke protective re-
sponses in mice after S. Typhimurium infection. To address
this failure, we hypothesized that S. Typhimurium is able to inac-
tivate MCs. In order to test this notion, we injected late-log-
phase S. Typhimurium SL1433 into the peritoneal cavity of WT
and KitW-sh/KitW-sh (MC-deficient) mice. We chose the perito-
neum for the following reasons: (1) it is a self-contained body
site where bacterial numbers and neutrophil influx can be simul-
taneously and conveniently assessed, (2) bacteria can directly
interact with MCs, and (3) MCs can be readily visualized in the
peritoneal fluid for determining the activation status by the
evaluation of cell morphology. Interestingly, we observed no
significant difference in the bacterial burdens of peritoneal
lavage between WT and MC-deficient mice upon infection
with S. Typhimurium (Figure 1A, top). Consistent with this
finding, myeloperoxidase (MPO) assays of lavage revealed no
significant difference in neutrophil influx between the two
groups of mice (Figure 1A, bottom). In contrast, when E. coli
J96 was intraperitoneally injected into the two mouse strains,
a significant difference in bacterial clearance was observed
between WT and MC-deficient mice (Figure 1B, top). This
observation correlated with a higher neutrophil influx in WT
mice than in MC-deficient mice (Figure 1B, bottom). The lack
of an appreciable difference in bacterial load between WT and
MC-deficient mice is consistent with previous reports that found
no clear protective function for MCs during S. Typhimurium
infection (Piliponsky et al., 2010). To determine whether our
observations could be related to differential MC activation
upon contact with different pathogens, we investigated the
morphology of MCs in the peritoneal fluid (Figure 1C, top) and
mesentery (Figure 1C, bottom) of both groups of mice. For
comparative purposes, we also examined MCs from PBS-in-
jected mice. MCs from mice challenged with E. coli J96 were
not readily visible by toluidine blue staining, given that they
were extensively degranulated (there was an observable spray
of isolated granules around each MC; Figure 1C, middle). In
contrast, MCs from mice challenged with S. Typhimurium
were readily detectable and fully granulated (Figure 1C, right)unity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc. 1109
Figure 1. S. Typhimurium Fails to Elicit MC
Activation and Subsequent Neutrophil
Recruitment andBacterial Clearance In Vivo
(A and B) The top graphs show residual bacterial
counts (CFU) in the peritoneal cavity of WT or MC-
deficient mice 24 hr after intraperitoneal infection
with 5 3 105 CFU of S. Typhimurium or 1 3 107
CFU of E. coli. The bottom graphs show myelo-
peroxidase assays of peritoneal lavage of WT or
MC-deficient mice 5 hr postinfection with 1 3 107
CFU of S. Typhimurium or E. coli J96.
(C) Morphologic appearance of MCs in the
peritoneum (top) and mesentery (bottom) of WT
mice 3 hr after intraperitoneal infection of 1 3 108
CFU of S. Typhimurium or E. coli J96. Insets
represent 603 magnification of MCs in the
mesentery. Images represent three independent
experiments. Scale bars in the top panels and in-
sets represent 20 mm, and scale bars in the bottom
panels represent 100 mm. Each panel is repre-
sentative of four mice.
(D) Granulated MC numbers in peritoneal lavages
(top) or mesentery whole mounts (bottom) were
quantified by the number of partially and fully
granulated MCs per field (n = 3–5 from 5 randomly
chosen fields). Wholly degranulated MCs could
not be detected.
Data represent the mean ± SEM. *p < 0.05, **p <
0.01. NS, not significant.
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ure 1C, left). Quantification of fully and partially granulated
MCs at both of these sites is provided in Figure 1D. These
observations collectively suggest that, unlike the MCs that
responded vigorously to E. coli J96, MCs challenged with S.
Typhimurium were incapable of evoking a degranulation
response. Consequently, limited neutrophil responses and cor-
responding bacterial clearance were observed in mice infected
with S. Typhimurium.
S. Typhimurium Actively Suppresses Degranulation of
Murine and Human MCs
To more closely investigate the limited MC degranulation
response to S. Typhimurium, we utilized the MC model cell
line rat basophil leukemia 2H3 (RBL-2H3) in standard in vitro
b-hexosaminidase-release assays to assess MC degranulation
activity after exposure to S. Typhimurium, E. coli J96, or iono-
mycin, a potent MC secretagogue that works by triggering
intracellular calcium flux (Gilfillan and Tkaczyk, 2006). Whereas
ionomycin and E. coli J96 evoked significant responses, no
degranulation was observed in response to S. Typhimurium or
PBS (Figure 2A). Compared to dose-dependent MC degranula-
tion observed with E. coli J96 (Figure 2B, left), the degranulation
response to S. Typhimurium was minimal (Figure 2B, right).1110 Immunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc.The limited MC degranulation to S.
Typhimurium could potentially be attrib-
utable to the ability of S. Typhimurium to
actively block MC degranulation or to
the inability of MCs to evoke a response
to S. Typhimurium. To test the latter
possibility, we exposed MCs to live andheat-killed S. Typhimurium and observed that MCs failed to
degranulate to either stimulus, indicating that the MCs were
inherently unresponsive to S. Typhimurium (Figure 2C, left).
Next, to investigate whether S. Typhimurium also possesses
the ability to inhibit MC degranulation, we pretreated MCs
with live or heat-killed S. Typhimurium and then exposed the
cells to the potent secretagogue ionomycin. We found that in
contrast to heat-killed S. Typhimurium, live S. Typhimurium
was able to block subsequent MC responses to ionomycin
(Figure 2C, right), indicating that S. Typhimurium has the innate
capacity to actively block MC degranulation. To assess the
specificity of this activity, we pretreated MCs with live E. coli
strain CI5 or the Gram-positive pathogen Staphylococcus
aureus and found that neither of these bacteria was able to inhibit
the MC degranulation to ionomycin (Figure 2D).
Because these observations were made in a rodent cell line,
we sought to confirm them in the LAD2 human MC cell line. Pre-
treatment of human MCs with S. Typhimurium blocked subse-
quent responses not only to ionomycin but also to other known
secretagogues, C48/80 and complement fragment C5a (Fig-
ure 2E). This suggests that S. Typhimurium possesses both the
ability to circumvent MC activation and the capacity to suppress
the MC degranulation response to activators by utilizing distinct
signaling pathways, implying a multipronged inhibitory activity.
Figure 2. S. Typhimurium Pretreatment Actively Suppresses MC
Degranulation to MC Secretagogues
(A and B) In vitro b-hexosaminidase release assays of rat basophil leukemia
(RBL) cells after 1 hr exposure to S. Typhimurium (STm) or E. coli J96. The
effect of bacterial multiplicities of infection (10:1, 100:1, and 1,000:1) on MC
degranulation is also shown in (B).
(C and D) b-hexosaminidase release by RBL cells after 1 hr exposure to live or
heat-killed (60C for 1 hr) STm (HK-Stm) (C, left graph) and RBL cell degran-
ulation to ionomycin after 30 min pretreatment with live or HK-STm (C, right
graph) and to various bacteria (D).
(E) LAD2 degranulation to ionomycin (left), C48/80 (middle), or C5a (right) after
30 min pretreatment with live STm or PBS (control).
Data represent the mean ± SEM. *p < 0.001, **p < 0.01, ***p < 0.05. NS, not
significant.
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N-Ethylmalemide-Sensitive Factor
Virulence factors associated with S. Typhimurium are typically
encoded by genes located in one or more pathogenicity islands.
Therefore, we examinedS. Typhimurium-null mutants for the two
best characterized pathogenicity islands, SPI1 and SPI2, as well
as a double mutant (SPI1&SPI2) for their ability to block MC
degranulation. We found that in contrast to the SPI2 mutant
(DSPI2), the SPI1 mutant (DSPI1) and the double SPI1&SPI2Immmutant (DSPI1&2) failed to block ionomycin-induced degranula-
tion (Figure 3A). The SPI1 T3SS translocates multiple effectors
directly into host cells, many of which activate or impede specific
cellular functions (Haraga et al., 2008). Given that MC degranu-
lation requires a tyrosine phosphorylation cascade (Gilfillan
and Tkaczyk, 2006), we postulated that a possible MC suppres-
sor could be SptP, a known SPI1 effector with distinct phospha-
tase and GTPase activities (Kaniga et al., 1996).
To investigate the role of SptP in suppressing MC activity, we
first compared the ability of WT S. Typhimurium and an isogenic
mutant, DsptP, to prevent degranulation. We used immuno-
globulin E (IgE) and antigen as the MC stimulant because this
well-characterized signaling pathway has several potential
targets for phosphatase activity. We found that in the case of
MCs pretreated with DsptP, the degranulation response to IgE
stimulation was no longer inhibited and was even higher than
that seen with IgE stimulation (Figure 3B). One possibility for
the enhanced degranulation response of DsptP-treated MCs is
that the GTPase-activating protein domain of SptP also has a
known effect promoting recovery of the cellular cytoskeleton
after Salmonella-mediated invasion (Fu and Gala´n, 1999). In
the absence of reorganized cytoskeleton, as is the case with
DsptP, MCs degranulate excessively after stimulation (Fo¨ger
et al., 2011).
Next, we undertook a series of complementation studies to
identify the relevant region in the functionally distinct domains
located at either end of SptP. To distinguish the effects between
the GTPase-activating function of the amino-terminal region and
the protein tyrosine phosphatase function associated with the
carboxy-terminal region (Fu and Gala´n, 1999; Kaniga et al.,
1996), we complemented DsptP S. Typhimurium with plasmid
psptPWT (encoding WT sptP), psptPC481S (encoding sptP with
an inactive phosphatase domain), or psptPR209A (encoding
sptP with an inactive GTPase domain) and compared the ability
of the complemented strains to suppress MC degranulation
(Figure 3B). Compared to uncomplemented DsptP, complemen-
tation with psptPWT or psptPR209A, but not psptPC481S, inhibited
MC degranulation. These results suggest that SptP, and specif-
ically the catalytic activity of its tyrosine phosphatase domain,
mediates MC degranulation.
To investigate whether SptP has the inherent ability to sup-
press MC degranulation, we cloned and expressed SptP intra-
cellularly in the RBL-2H3 MCs by stably transfecting with
SptP-eGFP, resulting in SptP expression in approximately 60%
of cells on the basis of fluorescent activity (Figure S1, available
online). We next examined the effects of SptP expression on
the MC degranulation response to IgE and anti-IgE in RBL-2H3
cells. We observed that compared to controls, RBL-2H3 MCs
transfected with SptP-eGFP exhibited a significant (60%)
reduction in degranulation (Figure 3C).
To facilitate SptP trafficking into the MC cytosol via non-
endocytic pathways after exogenous treatment of SptP, we
constructed a membrane-permeable SptP by conjugating it to
the short peptide RKKRRQRRR, derived from the HIV TAT
(transactivator of transcription) protein, which can translocate
itself into the cytosol of various host cells (Gump and Dowdy,
2007). To observe SptP-TAT penetrance into bone-marrow-
derived mast cells (BMMCs), we employed confocal microscopy
to visualize the protein within BMMCs. We opted to employunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc. 1111
Figure 3. The Protein Tyrosine Phosphatase Domain of the SPI-1 Effector, SptP, Inhibits MC Degranulation through Dephosphorylating Syk
and NSF
(A) MC degranulation to ionomycin after 30 min pretreatment with WT, DSPI1, DSPI2, or DSPI1&2 STm strains.
(B) Degranulation of IgE-sensitized MCs to antigen (Ag, TNP-OVA) after 45 min pretreatment with WT, DsptP, or complemented DsptP strains (DsptP(psptPWT),
DsptP(psptPC481S), or DsptP(psptPR209A)).
(C) Degranulation of IgE-sensitized MCs expressing retrovirally transduced eGFP or SptP-eGFP to anti-IgE.
(D) Confocal microscopy of BMMCs exposed to SptP-TAT for 4 hr. MC granules were probedwith avidin (green), and intracellular SptP-TATwas probedwith anti-
His6 (red).
(legend continued on next page)
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RBL-2H3 cell line are also applicable to primary MCs. We
observed that SptP-TAT readily entered BMMCs and could
even be detected in the nuclei (Figure 3D, bottom). Because of
its superior ability to penetrate MC membranes, we predicted
that SptP-TAT would effectively block the MC degranulation
response. We observed that in contrast to controls, SptP-TAT
significantly inhibited IgE- and anti-IgE-mediated degranulation
in a dose-dependent manner (Figure 3E). We also generated a
catalytically inactive form of SptP-TAT (SptPC481S-TAT) that
had been observed in cytosol and nuclei (data not shown) to
specifically ablate the tyrosine phosphatase activity. Unlike
SptP-TAT, recombinant SptPC481S-TAT was unable to inhibit
IgE- and anti-IgE-mediated BMMC degranulation (Figure 3F),
confirming that SptP inhibits degranulation by using its tyrosine
phosphatase activity.
Next, we sought to localize sites of tyrosine phosphorylation
in MCs during degranulation and determine their activation after
exposure to SptP-TAT. Confocal microscopy employing probes
for MC granules and phosphotyrosine revealed that tyrosine
phosphorylation in BMMCs appeared to be localized primarily
to empty compartments where granules were housed prior to
activation with IgE and anti-IgE (Figure 3G, middle, arrow-
heads). This is consistent with the notion that tyrosine kinase
activity is important not only in the signaling events leading to
degranulation but also in the final stages of granule release
(Mustelin et al., 2005). We thus hypothesized that intracellular
SptP could interfere with the regulation of the granule secretory
pathway to block MC degranulation. In SptP-TAT-treated
BMMCs (Figure 3G, right), which did not degranulate after
exposure to IgE and anti-IgE, no tyrosine phosphorylation was
observed in the granule chambers, which is consistent with a
lack of degranulation. Notably, detectable amounts of SptP
were localized to the granule compartments. Thus, the absence
of tyrosine phosphorylation proximal to sites of granule
discharge contributes to abrogated MC degranulation in SptP-
TAT-treated MCs.
The SptP-TAT-associated absence of tyrosine phosphoryla-
tion in MCs led us to seek putative SptP targets in the IgE
signaling pathway. Syk, a tyrosine kinase, is an important
substrate in IgE-mediated MC degranulation (Gilfillan and Tkac-
zyk, 2006; Masuda and Schmitz, 2008), and we thus examined
the effects of SptP on Syk activation after IgE-mediated acti-
vation. SptP overexpression in transfected MCs markedly
suppressed Syk phosphorylation after stimulation with IgE and(E and F) Degranulation of IgE-sensitized BMMCs to anti-IgE after 4 hr pretreatm
pretreatment with SptP-TAT (5 mg) or SptPC481S-TAT (5 mg) (F).
(G) Morphological appearance of IgE-sensitized BMMCs to anti-IgE after 2 hr pret
avidin (red); SptP-TAT, anti-His6 (green); and intracellular tyrosine phosphorylatio
(H) Immunoblots of cell preparations from IgE-sensitized RBL cells stably express
for 1 hr (bottom) before activation with anti-IgE. The cell preparations from both ex
IgE. Immunoblots were probed with anti-p-Syk, anti-Syk, and anti-b-actin.
(I) Morphology of RBL cells after exposure toWT orDsptP STm. After 1 hr of treatm
as follows: MC granules, anti-serotonin (green); NSF, anti-NSF (red); and actin, p
(J) Morphology of RBL cells after exposure to WT or DsptP STm. After 1 hr treatm
phosphorylation and were stained with antibodies for fluorescence microscopy. S
sites, anti-p-Tyr (green); and actin, phalloidin (blue).
(K) Lysates from RBL cells were analyzed by immunoprecipitation and immunob
Data represent the mean ± SEM. *p < 0.001, **p < 0.01, ***p < 0.05. NS, not sign
Immanti-IgE (Figure 3H, top). To further confirm the role of Syk, we
also compared IgE-mediated Syk phosphorylation between
MCs pretreated with WT and DsptP S. Typhimurium. Consistent
with SptP overexpression, WT S. Typhimurium markedly sup-
pressed Syk phosphorylation, whereas DsptP S. Typhimurium
failed to do so. Indeed, DsptP S. Typhimurium appeared to
enhance Syk phosphorylation, indicating that in the absence of
SptP, Salmonella might directly activate MCs and that the
signaling events involve Syk (Figure 3H, bottom).
We also noticed that although granules of RBL-2H3 cells were
not released after 1 hr exposure to WT S. Typhimurium, they
appeared to have fused with each other to result in abnormally
large intracellular granules (Figure 3I, middle). However, this
phenotype was not observed in MCs exposed to DsptP
S. Typhimurium (Figure 3I, right). A critical determinant of MC
degranulation is N-ethylmalemide-sensitive factor (NSF), a
vesicle fusion protein localized to the cytoplasmic side of the
granule membrane (Benhamou and Blank, 2010; Mustelin
et al., 2005). In the steady state, NSF is typically phos-
phorylated, which is important for keeping MC granules from
spontaneous intracellular fusion (Huynh et al., 2004). Upon
MC activation, NSF became dephosphorylated, promoting
fusion of granule membranes to plasma membranes and thus
resulting in extracellular release of MC granules. We suspect
that in MCs infected with WT S. Typhimurium, NSF is prema-
turely dephosphorylated and thus results in granule fusion
without extracellular release. To validate this notion, we stained
MCs treated with PBS (control), WT S. Typhimurium, and DsptP
S. Typhimurium for NSF. In all cases, NSF colocalized to the
outer surface of MC granules (Figure 3I). Furthermore, the gran-
ules of MCs infected with WT S. Typhimurium appeared two to
three times the size of regular granules of control MCs and MCs
infected with DsptP S. Typhimurium, suggesting intergranular
fusion in the former (Figure 3I). To determine whether intergran-
ular fusion is associated with dephosphorylation of NSF, we
examined phosphorylation of NSF around MC granules and
found that whereas NSF appeared phosphorylated around MC
granules of MCs treated with PBS or DsptP S. Typhimurium,
this was not the case in MCs treated with WT S. Typhimurium
(Figure 3J, middle). Furthermore, when we immunoprecipitated
NSF from the three groups of MCs and probed with anti-phos-
photyrosine on an immunoblot, we observed that in contrast to
the other two conditions, NSF in MCs infected with WT S. Typhi-
murium was markedly dephosphorylated (Figure 3K), providing
support to our notions of premature intergranular fusion inducedent with increasing amounts of SptP-TAT (10, 1, and 0.1 mg) (E) or after 2 hr
reatment with vehicle or SptP-TAT (10 mg). Staining is as follows: MC granules,
n sites, anti-phosphotyrosine (p-Tyr) (blue).
ing either SptP-eGFP or control eGFP (top) or pretreated withWT orDsptP STm
periments were obtained at the indicated time points after activation with anti-
ent, cells were stained with antibodies for fluorescencemicroscopy. Staining is
halloidin (blue).
ent, cells were treated with vanadate (100 mM) for 5 min for preserving tyrosine
taining is as follows: NSF, anti-NSF (red); intracellular tyrosine phosphorylation
lotting for p-Tyr and NSF.
ificant. Scale bars represent 20 mm. See also Figures S1 and S2.
unity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc. 1113
Figure 4. Y. pestis YopH Suppresses MC
Activation
(A) Degranulation to ionomycin of RBL cells pre-
treated for 30 min with PBS or Y. pestis KIM5.
(B and C) RBL cells were retrovirally transduced
with control eGFP or YopH-eGFP before IgE and
antigen (IgE+Ag) stimulation (TNP-OVA) and
assayed for degranulation (B) or subjected to
confocal microscopy (C). Granules were stained
with anti-serotonin (red), and tyrosine phosphor-
ylation sites were stained with anti-p-Tyr (blue).
Scale bars represent 10 mm.
(D) Degranulation to IgE+Ag (TNP-OVA) RBL cells
after exposure to increasing concentrations of
purified YopH-TAT.
Data represent the mean ± SEM. *p < 0.001, **p <
0.01.
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downstream of Syk can also be inferred by the fact that WT
S. Typhimurium, but not DsptP and DsptP(psptPC481S), blocked
ionomycin-induced degranulation (Figure S2), which acts down-
stream of receptor-mediated MC signaling events (Gilfillan and
Tkaczyk, 2006).
A Homologous Tyrosine Phosphatase Produced by
Y. pestis Blocks MC Degranulation
We have noted that SptP shares appreciable homology with
phosphatases naturally found in MCs to prevent excessive
activation (Kaniga et al., 1996; Wang et al., 2002; data not
shown). Y. pestis is another Gram-negative pathogen that
expresses a potent tyrosine phosphatase, YopH, which shares
marked structural homology with SptP (Kaniga et al., 1996; Steb-
bins, 2004). Importantly, this enzyme is also injected into host
cells via T3SS (Cornelis, 2002). In view of the similarities in terms
of structure and delivery of these phosphatases, we speculated
that MC suppression might be an evolved virulence trait shared
among sophisticated pathogens such as S. Typhimurium and
Yersinia and hypothesized that YopH could also suppress MC
degranulation. We exposed MCs to a WT laboratory strain of
Y. pestis (KIM5) and examined the subsequent ability of these
MCs to mount degranulation to ionomycin. Y. pestis-exposed
MCs exhibited a significantly inhibited degranulation (Figure 4A).
To determine whether YopH was the specific Yersinia factor
involved in MC suppression, we cloned and expressed this
tyrosine phosphatase in RBL-2H3 cells. In contrast to control
eGFP-transfected cells, MCs transfected with YopH-eGFP had
limited degranulation to IgE and antigen (Figure 4B). Figure 4C
demonstrates the intracellular expression of YopH, the granula-
tion status of treatedMCs, and tyrosine phophorylation of eGFP-
and YopH-eGFP-transfected RBL-2H3 cells after exposure to1114 Immunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc.IgE and antigen. In particular, MC
degranulation seemed directly correlated
with tyrosine phosphorylation in empty
granule chambers (Figure 4C, middle,
arrow heads) of IgE- and antigen-
activated control MCs, but not in YopH-
expressing MCs (Figure 4C). Next, we
cloned and expressed YopH as a fusionprotein with TAT. To determine whether exogenous YopH-TAT
would inhibit MC degranulation, we exposed IgE-sensitized
MCs to increasing concentrations of YopH-TAT and examined
their responses to antigen-induced activation. We observed a
significant and dose-dependent suppression of the MC degran-
ulation response to antigen (Figure 4D). Taken together, these
observations indicate that YopH shares the ability of SptP to
suppress degranulation and suggest that MC suppression could
be an important virulence trait among host-adapted pathogens.
DsptP S. Typhimurium Induces MC Degranulation,
Neutrophil Influx, and Bacterial Clearance
To investigate the in vivo contribution of SptP toMC suppression
during S. Typhimurium infection, we challenged the peritoneal
cavities of mice with WT or DsptP S. Typhimurium (Figure 5A)
and determined that MCs isolated from the peritoneal cavities
exhibited widely different phenotypes in terms of their granula-
tion status. MCs exposed to WT S. Typhimurium remained fully
granulated (Figure 5A, third column), but MCs exposed to DsptP
S. Typhimurium underwent extensive degranulation (Figure 5A,
fourth column).When quantitated, this degranulation in response
to DsptP was comparable to the degranulation observed with
E. coli J96 (Figure 5B), which was included for comparative
purposes. The vacant granule chambers in extensively degranu-
lated MCs stained strongly for tyrosine phosphorylation (Fig-
ure 5A, fourth column, arrowhead), whereas granule chambers
in MCs exposed to S. Typhimurium or PBS failed to exhibit tyro-
sine phosphorylation staining. We observed that the overall
phosphotyrosine fluorescence in DsptP-infected MCs was
markedly higher (Figure 5A, fourth column) than that in E. coli-
infected MCs. This enhanced tyrosine phosphorylation was pre-
viously observed in DsptP-exposed MCs in vitro (data not
shown); these MCs also consistently exhibited higher Syk
Figure 5. Infection of Mice with DsptP Acti-
vates MCs and Enhances Neutrophil
Recruitment and Bacterial Clearance
Compared to WT
(A) 13 108 CFU of WT STm, DsptP STm, or E. coli
J96 were injected intraperitoneally. Peritoneal
lavage was harvested 4 hr later, cytospun, and
stained with toluidine blue for bright-field micro-
scopy (top) or with anti-serotonin (red) for granules
and anti-p-Tyr (blue) for immunofluorescence mi-
croscopy.
(B) Granulated MC numbers in peritoneal lavages
of (A) were quantified by the number of partially
and fully granulated MCs per field (n = 3–6 in 5
randomly chosen fields). Wholly degranulated
MCs could not be detected.
(C and D) Assays for neutrophil recruitment (MPO)
(C) and bacterial clearance (CFU) (D) were per-
formed on lavages collected 4 and 24 hr, respec-
tively, after intraperitoneal injection of 13 106 CFU
of WT or DsptP STm. Each graph is representative
of four mice.
Data represent the mean ± SEM. *p < 0.05, **p <
0.01. Scale bars represent 20 mm. See also
Figure S3.
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(Figure 3H, bottom). This is potentially due to the fact that
significantly higher degranulation was observed with DsptP S.
Typhimurium than with the positive degranulation control
(Figure 3B). Given that MC degranulation has been closely asso-
ciated with neutrophil recruitment and subsequent bacterial
clearance, we compared neutrophil responses in the peritoneum
of mice after 4 hr challenge with WT or DsptP S. Typhimurium.
Predictably, we observed significantly higher neutrophil
responses with DsptP than with WT S. Typhimurium (Figure 5C),
and this correlated with greater clearance ofDsptP than ofWT S.
Typhimurium 24 hr after bacterial challenge (Figure 5D).
Additionally, there were lower neutrophil responses and
bacterial clearance with the complemented mutant strain,
DsptP(psptPWT) (Figure S3).
S. Typhimurium Utilizes SptP to Inhibit MC-Dependent
Neutrophil Influx and Bacterial Clearance
Given the intrinsic ability of SptP to block MC degranulation,
previous studies have not been able to demonstrate a specificImmunity 39, 1108–1120, Derole for MCs in combating S. Typhimu-
rium infections in WT and MC-deficient
mice. Indeed, when we initially compared
neutrophil responses and bacterial
clearance between WT and MC-deficient
mice after intraperitoneal challenge with
WT S. Typhimurium, we failed to notice
any appreciable difference between the
two strains of mice (Figures 1A and 1C).
However, on the basis of our subsequent
findings, we sought to demonstrate a
potential MC response to S. Typhimurium
by employing our DsptP mutant strain.
We compared neutrophil responses andbacterial clearance ofDsptP S. Typhimurium inWT andMC-defi-
cient mice after peritoneal challenge. Neutrophil responses to
DsptP S. Typhimurium were significantly more elevated in WT
mice than in MC-deficient mice (Figure 6A, top), and this was
accompanied by better clearance of DsptP S. Typhimurium in
WT mice 24 hr after bacterial challenge (Figure 6A, bottom).
To demonstrate the potency of the MC-suppressing activity
of SptP-TAT, we coadministered recombinant SptP-TAT
intraperitoneally with E. coli J96, which normally activates
MCs, and examined neutrophil recruitment and bacterial
clearance. Compared to E. coli J96 alone, E. coli J96 coin-
stilled with SptP-TAT evoked lower neutrophil responses and
bacterial clearance from the peritoneum (Figure 6B). To verify
that this weak neutrophil response was linked to MCs, we exam-
ined isolated peritoneal MCs and found that those from mice
challenged with E. coli J96 with SptP-TAT were undegranulated
(Figure 6C, right column) in comparison to those from mice
challenged with E. coli J96 alone (Figure 6C, middle column,
quantitated in Figure 6D). Furthermore, these undegranulated
MCs exhibited a limited degree of tyrosine phosphorylationcember 12, 2013 ª2013 Elsevier Inc. 1115
Figure 6. DsptP S. Typhimurium Evokes
MC-Dependent Neutrophil Recruitment,
Bacterial Clearance, and Vascular Leakage
(A and B) Neutrophil influx (top) and bacterial
counts (bottom) in (A) WT and MC-deficient mice
after intraperitoneal injection of 5 3 105 CFU of
DsptP STm or in (B) WT mice after intraperitoneal
injection of SptP-TAT (100 mg per mouse) or
vehicle followed 30 min later by intraperitoneal in-
jection of 13 107 CFU of E. coli. MPO assays were
performed 5 hr postinfection, and CFU were
determined 24 hr postinfection.
(C) Morphology of MCs in the peritoneal cavities of
control and SptP-TAT-treated mice 3 hr after
E. coli infection. Staining is as follow: MC granules,
avidin (red); SptP-TAT, anti-His6 (green); and
tyrosine phosphorylation sites: anti-p-Tyr (blue).
Scale bars represent 20 mm.
(D) Granulated MC numbers in peritoneal lavages
of (C) were quantified by the number of partially
and fully granulated MCs per field (n = 5 in 5
random chosen fields). Totally degranulated MCs
could not be detected.
(E) Mouse ears were injected intradermally with
vehicle or SptP-TAT (20 mg) and injected 1 hr later
with 1 3 106 CFU E. coli J96 at the same site and
FITC-dextran (green) intravenously. One hour
postinfection, the ears were dissected, stained
with avidin (red) and anti-CD31 (blue), and whole
mounted for immunofluorescence microscopy.
Scale bars represent 50 mm.
Data represent the mean ± SEM. *p < 0.05, **p <
0.01. See also Figures S4–S6.
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in granule compartments (Figure 6C, right column).
MC-mediated neutrophil recruitment is also associated with
vascular leakage of serum components (including complement
and antibodies) that can markedly impact pathogen persistence
in tissue sites (Kunder et al., 2011; Nakamura et al., 2009). We
sought to examine the impact of SptP on MC-mediated vascular
leakage by assessing the tissue penetrance of intravenously
administered fluorescein isothiocyanate (FITC)-dextran. Fig-
ure 6E shows the whole-mount staining of mouse ears that
were intradermally injected with vehicle or SptP-TAT and sub-
sequently infected with E. coli J96. Given the large amount of
FITC-dextran in the perivascular space (Figure 6E, middle), tis-
sue injected with E. coli J96 tissue exhibited a high degree of
vascular leakage. A high degree of MC degranulation was also
observed in this tissue. In contrast, no vascular leakage or MC
degranulation was observed in tissue injected with E. coli and
SptP-TAT (Figure 6E, right). A significant reduction in vascular
leakage induced by SptP-TAT after E. coli J96 infection was
quantitatively measured by the examination of extravasated
Evans Blue in mouse ears (Figure S4). Additional whole-mount
staining revealed that SptP-TAT inhibited degranulation after
exposure to E. coli J96 (Figure S5) and that this inhibitor could1116 Immunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc.be detected in the cytosol of MCs in
infected tissue (Figure S6). Cumulatively,
these findings demonstrate that SptP is
a potent suppressor of MC-mediatedactivity and that in the absence of SptP, MCs most likely play
an antibacterial role during infection with S. Typhimurium.
Interactions between MCs and S. Typhimurium Most
Likely Occur Immediately after the Gut Epithelium Is
Breached
During natural infection, S. Typhimurium that successfully
breach the gut epithelial barrier typically target the mesenteric
lymph nodes, where they proliferate with limited interference
from the host immune system (Mastroeni et al., 2009). However,
before S. Typhimurium can reach the draining lymph nodes, the
bacteria must circumvent an array of MCs present in the lamina
propria of the gut epithelium. Shown in Figure S7 are sections of
the caecal epithelium of mice challenged with PBS,WT S. Typhi-
murium, or DsptP S. Typhimurium. Numerous fully granulated
MCs were seen proximal to the epithelium in mice challenged
with PBS or WT S. Typhimurium, but not in mice challenged
with DsptP S. Typhimurium; this latter group of mice was inca-
pable of suppressingMCs. Indeed, the apparent absence of fully
granulated MCs in the caecum of mice challenged with DsptP S.
Typhimurium was attributable to extensive MC degranulation
induced by the many mutant S. Typhimurium found at this site
(Figure S7). We investigated whether these MCs in the lamina
Figure 7. Intestinal MCs Reduce Bacterial Burden in Mesenteric
Lymph Nodes after Oral Infection with DsptP S. Typhimurium
CFU of mesenteric lymph nodes (mLNs) were assessed in streptomycin-
treated (A, C, and D) WT or MC-deficient mice and (B) WT or Cma1-cre+iDTR+
mice injected with diphtheria toxin after oral challenge with 5 3 107 CFU of
DsptP (A and B),DsptP(psptPC481S) (C), orDsptP(psptPWT) (D) S. Typhimurium.
The CFUs were assessed 24 hr postinfection. *p < 0.01, **p < 0.05. NS, not
significant. See also Figure S7.
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whether S. Typhimurium-mediated MC suppression had a func-
tion during natural infection. To address this question, we
assessed the number of bacteria that reached the mesenteric
lymph nodes in WT and MC-deficient mice shortly after oral
challenge with DsptP S. Typhimurium, which does not suppress
MCs. If gut-resident MCs contribute to bacterial clearance, we
would expect there to be fewer bacteria in the mesenteric lymph
nodes in MC-sufficient mice than in the MC-deficient mice. We
detected markedly greater numbers of bacteria in the immediate
draining lymph nodes of MC-deficient mice than in those of WT
mice 24 hr after oral infection with DsptP S. Typhimurium (Fig-
ure 7A). Because some recent studies have questioned the use
of Kit-dependent MC-deficient mice (Dudeck et al., 2011; Feyer-
abend et al., 2011; Rodewald and Feyerabend, 2012), we
have also included here a recently described Kit-independent
inducible model of MC deficiency, involving Cma1-cre+iDTR+
mice (Dudeck et al., 2011). Using this model, we obtained
very similar findings regarding the contribution of MCs in the
clearance of DsptP S. Typhimurium (Figure 7B). Additionally,
we confirmed the contribution of the phosphatase domain
of SptP by challenging WT and MC-deficient mice with
DsptP(psptPC481S) S. Typhimurium (Figure 7C). To confirm that
the SptP deletion was responsible for MC-dependent bacterial
clearance, we also infected WT and MC-deficient mice with
DsptP(psptPWT) S. Typhimurium (Figure 7D). Predictably, we
observed that the bacterial burden in MC-sufficient mice was
comparable to that of MC-deficient mice. This result is alsoImmconsistent with the data demonstrating that the WT S. Typhimu-
rium burden was comparable in MC-sufficient and MC-deficient
mice (Figure 1A). Thus, MCs have the potential to regulate the
colonization of the mesenteric lymph nodes, which are among
the first sites targeted by pathogens that successfully breach
the gut barrier.
DISCUSSION
In this study, we revealed that S. Typhimurium employs a highly
effective mechanism involving the inactivation of MCs, immune
surveillance cells strategically located at host-environment inter-
faces, to elude host innate immunity. We demonstrated that
unlike E. coli J96, which provoked rapid and extensive MC
degranulation, S. Typhimurium not only failed to elicit the MC
degranulation response but also prevented MC responses to a
wide array of potent secretagogues, such as IgE and antigen,
calcium ionophore, and complement, revealing a broad and
powerful inhibitory activity. This capacity to block MC responses
to other signals is relevant during infection because even though
S. Typhimurium do not activateMCs per se, various endogenous
danger signals or alarmins that can potentially activate MCs are
released at infection sites (Enoksson et al., 2013; Liew et al.,
2010). In vivo studies in mice revealed that this innate capacity
of S. Typhimurium to block MC degranulation markedly reduced
neutrophil responses and limited bacterial clearance at the infec-
tion site. This is in sharp contrast to the mechanism of E. coli,
which elicited extensive MC degranulation, a strong neutrophil
response, and marked bacterial clearance from the site of
infection. This capacity to elude early innate immune responses
by inactivating peripheral MCs could explain, at least in part, the
well-recognized ability of S. Typhimurium to avoid clearance
by the innate immune system and to disseminate rapidly from
the site of infection to distal sites such as the draining lymph
nodes and liver (Mastroeni et al., 2009). Our observation that
S. Typhimurium inhibited early neutrophil recruitment is not
inconsistent with earlier reports of strong neutrophil responses
after S. Typhimurium infection (Cheminay et al., 2004; Yang
et al., 2002). In this study, we focused on a narrow window of
time during the early stages of the infection process but
observed the development of a vigorous MC-independent
neutrophil response at sites of infection with WT S. Typhimurium
after the initial lag period (data not shown). Our findings imply
that the initial immune response to a pathogen is an important
determinant of infection outcome. Regardless of its intensity, a
delayed neutrophil response at the site of S. Typhimurium infec-
tion could have limited protective value because many of the
bacteria are either intracellular or have become systemic at
that point.
The ability of S. Typhimurium to block MC activity could, at
least in part, explain why others have not been able to demon-
strate a protective role for MCs (Chatterjea et al., 2005). Much
of our conclusions were based on using traditional Kit-mutant
MC-deficient mice; however, given that this model of MC
deficiency has been challenged recently (Dudeck et al., 2011;
Feyerabend et al., 2011; Rodewald and Feyerabend, 2012), we
sought to confirm our findings by employing Kit-independent
Cma1-cre+iDTR+ mice, in which MC deficiency was inducible.
Our findings utilizing the inducible model of MC deficiencyunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Inc. 1117
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dation of our conclusions.
S. Typhimurium-mediated suppression of MC degranulation
was achieved through the introduction of SptP into the MC
cytosol. The suppressing actions of SptP are restricted to the
exocytic function of MCs because MCs readily internalize S.
Typhimurium upon contact. SptP is a SPI1 effector protein with
two functional domains. The N-terminal domain functions during
pathogen entry into host cells by deactivating Rho GTPases and
reversing pathogen-induced cytoskeletal changes after S.
Typhimurium uptake (Fu and Gala´n, 1999). The second, C-termi-
nal domain comprises a protein tyrosine phosphatase reported
to function late in the pathogen entry process when S. Typhimu-
rium is harboredwithin late endosomes (Humphreys et al., 2009).
In these compartments, it is believed that SptP dephosphory-
lates a protein that facilitates cellular membrane fusion and
protein degradation and thus enhances intracellular S. Typhimu-
rium replication. The tyrosine phosphatase domain of SptP is
also thought to inactivate MAP kinase (Murli et al., 2001). Our
finding that the tyrosine phosphatase region of SptP mediates
MC inactivation represents a distinct function for this domain,
and our work with GTPase-inactive SptP and YopH, which lacks
a GTPase domain, suggests that GTPase activity is for the most
part dispensable for MC suppression. A comparison of the
primary structure of SptP with multiple tyrosine phosphatases
found in the cytosol of MCs reveals a high degree of homology
(Kaniga et al., 1996), implying multiple targets for this phospha-
tase. Morphological MC studies employing phosphotyrosine-
specific antibody probes revealed that degranulation was
closely associated with phosphorylation events at the cell sur-
face and at intracellular sites proximal to cytosolic granules.
Phosphorylation of these proteins at both sites did not occur in
the presence of SptP, suggesting that SptP acted at multiple
sites and on multiple targets. By examining S. Typhimurium-
infected MCs before or after activation with various secreta-
gogues, we were able to identify at least two distinct substrates
of SptP. Immunoblot analyses of S. Typhimurium-infected MCs
and control MCs after IgE-mediated activation revealed one of
the intracellular targets of SptP to be Syk, which is a member
of the Syk/Zap-70 family and a substrate found early in the
signaling cascade. Microscopic and immunoprecipitation
studies of MCs infected with WT S. Typhimurium also revealed
that shortly after infection, MC granules spontaneously coa-
lesced to form oversized granules, which failed to be expelled
upon subsequent exposure to potent secretagogues. This phe-
nomenon was not observed with DsptP S. Typhimurium, indi-
cating that it was an SptP-mediated activity. We have linked
this intergranular fusion to SptP-mediated dephophorylation of
NSF, a fusion protein whose functions include preventing homo-
typic intergranular fusion (Mustelin et al., 2005; Wang et al.,
2002).
Although a number of MC-inactivating compounds derived
from variousmicrobes, including the toxic fungal metabolite glio-
toxin (Cramer et al., 2006; Niide et al., 2006), ES-62, a glycopro-
tein secreted by filarial nematodes (Melendez et al., 2007),
FK506 from Streptomyces tsukubaensis (Narenjkar et al.,
2006), and cyclosporine A from Tolypocladium inflatum (Harrison
et al., 2007), have been identified, these do not, for themost part,
appear to be relevant in the pathogenesis of infection. Our1118 Immunity 39, 1108–1120, December 12, 2013 ª2013 Elsevier Instudies here reveal that two highly successful host-adapted
pathogens, S. Typhimurium and Y. pestis, share a powerful
mechanism to suppress MC degranulation, suggesting that
MC inhibition is an important virulence determinant. MCs are
one of the first types of immune cells encountered by these
pathogens after they traverse the epithelial barrier. They are
relatively abundant in dermal tissue, where Y. pestis is localized
after injection by fleas, and are also common in the gut epithe-
lium below Peyer’s patches and in the lamia propria, where
they can encounter S. Typhimurium invading through M cells
or gut epithelial cells (Jones et al., 1994). Orally administered
S. Typhimurium that successfully breach the epithelial barrier
traffic to the mesenteric lymph nodes, a process likely to be
influenced by MC interactions. Indeed, significantly higher
numbers of DsptP were present in the mesenteric lymph nodes
of MC-deficient mice after oral infection, implicating mucosal
MCs as primary responders to S. Typhimurium breaching the
gut epithelium.
MCs and MC-like cells are found in a wide range of animal
species, including less evolved species devoid of an adaptive
immunity. In recent years, it has become clear that MCs play a
key role in modulating innate immune responses to various
bacteria, parasites, viruses, and fungi, suggesting that the raison
d’eˆtre for these cells is modulation of immediate and nonspecific
immunity tomicrobial challenge. In view of this, it is not surprising
that certain virulent pathogens would have evolved special
mechanisms to inactivate these cells to prevent or delay host
immune responses and promote their pathogenesis.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture
S. Typhimurium SL1344 and SL1344-derived Tn5 transposon insertion
mutants SPI1, SPI2, and SPI1&2 were gifts from Alejandro Aballay (Duke
University). SB300 and its sptP deletion mutant, SB749, were gifts from Jorge
E. Gala´n (Yale University). DsptP(psptPWT), DsptP(psptPC481S), and
DsptP(psptPR209A) were generated in this study. Other strains used include
E. coli J96 andCI5, Gram-positive clinical isolateStaphylococcus aureus strain
54 (Duke University Medical Center), and a WT laboratory strain of condition-
ally virulent and naturally occurring Y. pestis (KIM5). Bacteria were grown for
15 hr, without shaking, in Luria-Bertani (GIBCO) broth at 37C; 25 mg/ml kana-
mycin was added for transposon mutants, 100 mg/ml streptomycin for SB300
and SB749, and 100 mg/ml carbenicillin for complemented strains.
Mice
C57BL/6 mice were purchased from the National Cancer Institute. MC-defi-
cient Wsh mice (KitW-sh/KitW-sh), their congenic littermate controls, and iDTR
mice were from Jackson Laboratories. For inducing MC depletion, 8-week-
old Cma1-cre+iDTR+ mice, a cross between Cma1-cre mice (a gift from Axel
Roers [University of Technology, Dresden]) and iDTRmice, andWT littermates
received five intravenous injections of 100 ng DT per mouse in a week. All
experiments were performed according to the protocols approved by the
Duke Division of Laboratory Animal Resources and the Duke University Insti-
tutional Animal Care and Use Committee.
Animal Infections and CFU Counts
Micewere infected intraperitoneally withS. Typhimurium or E. coli J96 in 100 ml
sterile PBS. At the indicated times, peritoneal lavage was performed with 5 ml
sterile, ice-cold PBS. Lavage was analyzed for MC degranulation, neutrophil
influx, or CFU (colony-forming units). Oral infection was as previously
described (Barthel et al., 2003). In brief, mice were pretreated with 20 mg
streptomycin prior to infection with 53 107 CFU of DsptP or its complemented
mutant S. Typhimurium. At various times, mice were sacrificed andmesentericc.
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Mast Cell Suppression by Salmonellalymph nodes were homogenized in 0.1% Triton X-100 per PBS. Lysates were
plated on MacConkey agar with or without 50 mg/ml streptomycin and incu-
bated overnight at 37C, and then CFU were assessed.
Enzymatic Assays
b-hexosaminidase and myeloperoxidase assays are described in the Supple-
mental Experimental Procedures.
Microscopy
Staining of cultured BMMCs, peritoneal cells, and mesentery and ear tissue is
described in the Supplemental Experimental Procedures. A Nikon ECLIPSE
TE200 microscope was used for obtaining confocal images via a channel-
series approach.
Statistical Analysis
Results were analyzed with a one-way ANOVA and Tukey’s post hoc test
together, a two-way ANOVA, or the Mann-Whitney t test, as appropriate,
with Prism (GraphPad) software. Differences between groups were consid-
ered significant at p < 0.05. All error bars represent the SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.immuni.2013.11.009.
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